| Literature DB >> 25232109 |
Miriam Melis1, Claudia Sagheddu2, Marta De Felice2, Alberto Casti2, Camilla Madeddu2, Saturnino Spiga3, Anna Lisa Muntoni4, Kenneth Mackie5, Giovanni Marsicano6, Giancarlo Colombo4, Maria Paola Castelli2, Marco Pistis7.
Abstract
The progressive predominance of rewarding effects of addictive drugs over their aversive properties likely contributes to the transition from drug use to drug dependence. By inhibiting the activity of DA neurons in the VTA, GABA projections from the rostromedial tegmental nucleus (RMTg) are well suited to shift the balance between drug-induced reward and aversion. Since cannabinoids suppress RMTg inputs to DA cells and CB1 receptors affect alcohol intake in rodents, we hypothesized that the endocannabinoid system, by modulating this pathway, might contribute to alcohol preference. Here we found that RMTg afferents onto VTA DA neurons express CB1 receptors and display a 2-arachidonoylglycerol (2-AG)-dependent form of short-term plasticity, that is, depolarization-induced suppression of inhibition (DSI). Next, we compared rodents with innate opposite alcohol preference, the Sardinian alcohol-preferring (sP) and alcohol-nonpreferring (sNP) rats. We found that DA cells from alcohol-naive sP rats displayed a decreased probability of GABA release and a larger DSI. This difference was due to the rate of 2-AG degradation. In vivo, we found a reduced RMTg-induced inhibition of putative DA neurons in sP rats that negatively correlated with an increased firing. Finally, alcohol failed to enhance RMTg spontaneous activity and to prolong RMTg-induced silencing of putative DA neurons in sP rats. Our results indicate functional modifications of RMTg projections to DA neurons that might impact the reward/aversion balance of alcohol attributes, which may contribute to the innate preference observed in sP rats and to their elevated alcohol intake.Entities:
Keywords: alcoholism; cannabinoid; dopamine; rostromedial tegmental nucleus; synaptic plasticity; ventral tegmental area
Mesh:
Substances:
Year: 2014 PMID: 25232109 PMCID: PMC4166158 DOI: 10.1523/JNEUROSCI.1844-14.2014
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167